| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antibody-drug conjugate [ADC] treatment of leukaemia
|
Hassan, Hassan Tawhid
|
|
|
131 |
C |
p.
|
article
|
| 2 |
Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia
|
Jain, Tania
|
|
|
131 |
C |
p.
|
article
|
| 3 |
Editorial Board
|
|
|
|
131 |
C |
p.
|
article
|
| 4 |
Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment
|
Wu, Xun
|
|
|
131 |
C |
p.
|
article
|
| 5 |
Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia
|
Martínez-Castillo, Macario
|
|
|
131 |
C |
p.
|
article
|
| 6 |
Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy
|
Atanasio, A.
|
|
|
131 |
C |
p.
|
article
|
| 7 |
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis
|
Mian, Agrima
|
|
|
131 |
C |
p.
|
article
|
| 8 |
Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort
|
Kaynar, Lale Aydın
|
|
|
131 |
C |
p.
|
article
|
| 9 |
Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemia
|
Bade, Rory
|
|
|
131 |
C |
p.
|
article
|
| 10 |
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis
|
Khanna, Vishesh
|
|
|
131 |
C |
p.
|
article
|
| 11 |
Should patients with acute myeloid leukemia treated with venetoclax-based regimens receive antifungal prophylaxis?
|
Guarana, Mariana
|
|
|
131 |
C |
p.
|
article
|
| 12 |
Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)
|
Mangaonkar, Abhishek A.
|
|
|
131 |
C |
p.
|
article
|
Journal description